CONTEXT: Building on established methods for CT virtual colonoscopy, Dr. Jamey Weichert, an associate professor of radiology at the University of Wisconsin, Madison, and colleagues tested a method for colonic tumor detection and characterization using PET/CT imaging.
CONTEXT: Building on established methods for CT virtual colonoscopy, Dr. Jamey Weichert, an associate professor of radiology at the University of Wisconsin, Madison, and colleagues tested a method for colonic tumor detection and characterization using PET/CT imaging. Iodine-124 NM404 (a radioiodinated phospholipid ether analog) was used as a PET tracer. NM404 has shown prominent tumor avidity and prolonged tumor retention in more than 30 preclinical malignant tumor types and in early clinical evaluation of lung cancer patients. Fluorine-18 FDG-PET was used for comparison. When labeled with iodine-125 or other radioisotopes commonly used in radiotherapy, NM404 has also shown promise as a radioimmunotherapeutic agent.
RESULTS: Two PIRC rats (a transgenic model for testing colon cancer progression) were injected with F-18 FDG followed 24 hours later by an injection of 124I-NM404. MicroPET and microCT scans were performed immediately following FDG injection and at 24 and 96 hours after NM404 injection. The in vivo NM404 microPET/microCT data distinguished three lesions as adenocarcinomas. Results confirmed a high degree of specificity for malignancy with NM404, while FDG did not differentiate between malignant and benign lesions.
IMAGE: In vivo microCT virtual colonoscopy fly-through of a PIRC rat indicates NM404 uptake in three potentially cancerous lesions.
IMPLICATIONS: The study is part of a larger program to establish clinical trials for NM404 dual-modality virtual colonoscopy. Future research will calculate standardized uptake values of NM404 versus FDG in colonic lesions in greater numbers of mice.
Emerging AI Algorithm Shows Promise for Abbreviated Breast MRI in Multicenter Study
April 25th 2025An artificial intelligence algorithm for dynamic contrast-enhanced breast MRI offered a 93.9 percent AUC for breast cancer detection, and a 92.3 percent sensitivity in BI-RADS 3 cases, according to new research presented at the Society for Breast Imaging (SBI) conference.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
Can Abbreviated Breast MRI Have an Impact in Assessing Post-Neoadjuvant Chemotherapy Response?
April 24th 2025New research presented at the Society for Breast Imaging (SBI) conference suggests that abbreviated MRI is comparable to full MRI in assessing pathologic complete response to neoadjuvant chemotherapy for breast cancer.
Clarius Mobile Health Unveils Anterior Knee Feature for Handheld Ultrasound
April 23rd 2025The T-Mode Anterior Knee feature reportedly offers a combination of automated segmentation and real-time conversion of grayscale ultrasound images into color-coded visuals that bolster understanding for novice ultrasound users.